title: Effects of thrombolysis and atenolol or metoprolol on the signal-averaged electrocardiogram after acute myocardial infarction. Late Potentials Italian Study (LAPIS).
abstract: Late potentials (LPs) detected on the signal-averaged (SA) electrocardiogram (ECG) predict arrhythmic events after acute myocardial infarction (AMI). The effect of thrombolysis on the incidence of LPs after AMI is controversial and its impact on subsequent arrhythmic events is not known. Moreover, the effects of beta blockers on the SAECG have not been studied. Six hundred eighteen patients with AMI were studied; thrombolysis was given to 228 (37%). In comparison with patients treated conventionally, those receiving thrombolysis were significantly younger and more frequently male, had higher peak values of creatine kinase, a lower prevalence of non-Q-wave AMI, and a higher incidence of ventricular fibrillation in the acute phase, and more frequently received beta blockers. An SAECG obtained 6 to 8 days after AMI showed LPs in 24% of patients receiving and in 25% not receiving thrombolysis (p = NS). On admission, intravenous beta blockers were administered to 110 patients (18%); those receiving beta blockers were younger, had lower peak values of creatine kinase and more frequently received thrombolysis. LPs were less frequently found in patients treated than in those not treated with beta blockers (15 vs 27%; p = 0.007); however, this effect was found only in those with an ejection fraction > or = 40%. Independent predictors of LPs by multivariate analysis were an ejection fraction < 40% (p = 0.007), ventricular fibrillation in the acute phase (p = 0.02), and absence of beta-blocking therapy (p = 0.03). During a mean follow-up of 12 +/- 7 months, there were 39 cardiac deaths (6%), 13 of which were sudden (2%), and 9 sustained ventricular tachycardias.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institute of Cardiology, Catholic University, Rome, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Santarelli
authors.forename: G A
authors.initials: GA
authors.lastname: Lanza
authors.forename: F
authors.initials: F
authors.lastname: Biscione
authors.forename: A
authors.initials: A
authors.lastname: Natale
authors.forename: G
authors.initials: G
authors.lastname: Corsini
authors.forename: C
authors.initials: C
authors.lastname: Riccio
authors.forename: E
authors.initials: E
authors.lastname: Occhetta
authors.forename: P
authors.initials: P
authors.lastname: Rossi
authors.forename: M
authors.initials: M
authors.lastname: Gronda
authors.forename: J
authors.initials: J
authors.lastname: Makmur
mesh_terms: D000368:Aged; D001262:Atenolol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004562:Electrocardiography / Q000187:drug effects* / Q000706:statistics & numerical data; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D011446:Prospective Studies; D012815:Signal Processing, Computer-Assisted; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data
chemical_list: D001262:Atenolol; D008790:Metoprolol